Holen Sie sich die Stockscreener-App
0.1826
5.99%
-0.0135
VolitionRX Ltd Aktie (VNRX) Neueste Nachrichten
VolitionRx announces automated Nu.Q Vet Cancer Test with Fujifilm Vet Systems - Yahoo Finance
VolitionRx shares jump as feline cancer blood test delivers strong accuracy results - MSN
VolitionRx (VNRX) Completes Key Phase for Nu.Q Vet Cancer Test i - GuruFocus
Volition announces first ever automated Nu.Q® Vet cancer test with Fujifilm Vet Systems - marketscreener.com
Automated cancer screening test set for Japan’s 7M pet dogs - Stock Titan
Tax withholding on VolitionRx (VNRX) shares for officer via RSU settlement - Stock Titan
VolitionRx (VNRX) CCO covers tax bill via 2,283-share cancellation - Stock Titan
Tax withholding trims VolitionRx (VNRX) GC Nicholas Plummer’s shares - Stock Titan
VNRX Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
VolitionRx issues shares to satisfy debt obligations and completes private placement - Investing.com
VNRX SEC FilingsVolitionrx 10-K, 10-Q, 8-K Forms - Stock Titan
VolitionRx (VNRX) grants CCO 149,000 RSUs in lieu of cash pay - Stock Titan
Ethel Rubin receives 178,000 RSU award at VolitionRx Ltd (VNRX) - Stock Titan
Executive at VolitionRx (VNRX) awarded 142,000 RSUs in lieu of cash pay - Stock Titan
VOLITIONRX (VNRX) CFO awarded 202,000 RSUs in lieu of cash pay - Stock Titan
119,000 RSUs granted to VolitionRx (VNRX) secretary in lieu of cash pay - Stock Titan
VolitionRx (VNRX) grants 187,000 RSUs to General Counsel Plummer - Stock Titan
[Form 4] VOLITIONRX LTD Insider Trading Activity - Stock Titan
VolitionRx (VNRX) executive receives 173,000 RSUs instead of cash pay - Stock Titan
VolitionRx (VNRX) grants CSO 149,000 RSUs instead of cash - Stock Titan
Director at VolitionRx (VNRX) granted 178,000 RSUs in lieu of cash - Stock Titan
VolitionRx advances cancer tests, expects French reimbursement By Investing.com - Investing.com India
VolitionRx Reports Clinical and Commercial Progress Across Cancer Detection and Sepsis Monitoring Platforms - citybuzz -
VolitionRx advances cancer tests, expects French reimbursement - Investing.com
VolitionRx Highlights Commercial Momentum and Multi-Pillar Execution - Yahoo Finance
VolitionRx issues shares to satisfy debt and completes private placement - Investing.com South Africa
VolitionRx (NYSE: VNRX) issues shares to repay Lind note - Stock Titan
VolitionRx issues shares to satisfy debt and completes private placement By Investing.com - Investing.com Canada
Q3 2025 VolitionRX Ltd Earnings Call Transcript - GuruFocus
Should You Buy VolitionRX Ltd (VNRX) Today? Analysis, Price Targets, and 2026 Outlook. - Intellectia AI
Armistice Capital reports 4.99% stake in VolitionRx (VNRX) — 6.45M shares - Stock Titan
Guidance Update: Is VolitionRx Limited gaining market share2025 Trading Volume Trends & Weekly Watchlist of Top Performers - baoquankhu1.vn
Volume Summary: Is now the right time to enter VolitionRx LimitedJuly 2025 Retail & Step-by-Step Trade Execution Guides - mfd.ru
VolitionRx nears 100 Nu.Q Discover clients, extends reach to Japan - Stock Titan
VolitionRx receives NYSE American non-compliance notice By Investing.com - Investing.com Australia
VolitionRx (VNRX) Plans to Offer Nearly 18 Million Shares - GuruFocus
VolitionRx (VNRX) Faces NYSE American Compliance Challenge - GuruFocus
VolitionRx Gets NYSE American Non-Compliance Notice for Failing Equity Requirements - marketscreener.com
VolitionRx Disclosed Failure to Satisfy a Continued Listing Rule or Standard - TradingView
VolitionRx stock gets 'below compliance' tag after NYSE warning - Stock Titan
Volume Report: Is VolitionRx Limited affected by consumer sentimentJuly 2025 Earnings & Intraday High Probability Setup Alerts - baoquankhu1.vn
VolitionRx Prepares French Reimbursement Submission for Nu.Q Cancer Blood Tests - MEXC
VolitionRx (VNRX) Moves Forward with French Reimbursement Submis - GuruFocus
VolitionRx Limited Announces the Preparation of Reimbursement Submission for its Nu.Q® Cancer Assays - Yahoo Finance
What is the cash position of VolitionRx LimitedWeekly Market Report & High Conviction Investment Ideas - mfd.ru
Aug Wrap: Is VolitionRx Limited benefiting from innovation trendsMarket Activity Report & Growth Focused Stock Pick Reports - baoquankhu1.vn
VNRX: D. Boral Capital Maintains Buy Rating and $3 Price Target - GuruFocus
VolitionRx (VNRX) Expands Nu.Q Vet Cancer Test Reach in U.S. and Asia - GuruFocus
Dog cancer blood test expands to all 50 states and parts of Asia - Stock Titan
VolitionRX (VNRX) Receives Buy Rating, Price Target Maintained a - GuruFocus
Why VolitionRx Limited stock is popular among millennialsEarnings Growth Report & Expert Curated Trade Setups - Улправда
VolitionRx Signs Amended Securities Purchase Agreement With Lind Global Asset Management XII - TradingView — Track All Markets
Is VolitionRx Limited stock trading near support levels2025 Key Lessons & Growth Oriented Trading Recommendations - Улправда
Volitionrx stock soars after feline cancer test shows high accuracy By Investing.com - Investing.com Nigeria
VolitionRx Limited Announces Breakthrough Clinical Data for Nu.Q Vet Cancer Test in Cats - marketscreener.com
1.05%
0.09%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):